{"id":"NCT03614494","sponsor":"Dr. Hang Wun Raymond Li","briefTitle":"Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception","officialTitle":"Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception: Randomised Controlled Trial","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2018-08-20","primaryCompletion":"2022-10-05","completion":"2022-10-05","firstPosted":"2018-08-03","resultsPosted":"2024-05-06","lastUpdate":"2024-05-06"},"enrollment":860,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Emergency Contraception"],"interventions":[{"type":"DRUG","name":"Piroxicam 40 mg","otherNames":[]},{"type":"DRUG","name":"Levonorgestrel 1.5mg","otherNames":[]}],"arms":[{"label":"Piroxicam","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomised controlled trial aimed at comparing the efficacy of levonorgestrel (LNG) co-administered with piroxicam or placebo for oral emergency contraception (EC). Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) commonly used as a pain-killer in inflammatory conditions. Efficacy will be measured as the percentage of pregnancies prevented.","primaryOutcome":{"measure":"Percentage of Pregnancies Prevented","timeFrame":"1 month","effectByArm":[{"arm":"Piroxicam","deltaMin":94.7,"sd":null},{"arm":"Placebo","deltaMin":63.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":11},"locations":{"siteCount":2,"countries":["Hong Kong"]},"refs":{"pmids":["37597523"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":430},"commonTop":["Fatigue / weakness","Nausea","Lower abdominal pain","Dizziness","Headache"]}}